PK is the cornerstone of every stage of drug development. From discovery to preclinical to clinical and post-marketing, PK/TK studies influence your development strategy, inform formulation development, identify exposure risks, and support dose selection and dosing regimen.
View and download this infographic for a brief overview of:
- Why does PK/TK matter?
- What NCA software should I use?
- What are regulators looking for in my PK/TK package?
- What are common PK myths and why are they inaccurate?
- How do you solve communication challenges between clinical operations and bioanalytical teams?
